S
Stephen Attwood
Researcher at Durham University
Publications - 143
Citations - 11575
Stephen Attwood is an academic researcher from Durham University. The author has contributed to research in topics: Eosinophilic esophagitis & Esophagus. The author has an hindex of 45, co-authored 132 publications receiving 10022 citations. Previous affiliations of Stephen Attwood include Newcastle University & Creighton University.
Papers
More filters
Journal ArticleDOI
Barrett's Dysplasia Cancer Task Force – Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus
Janusz Jankowski,Nimish Vakil,Mark K. Ferguson,Cathy Bennett,Paul Moayyedi,Jacques J. Bergman,Rebecca Harrison,Hugh Barr,John deCaestecker,John M. Inadomi,Nicholas J. Shaheen,Stephen J. Meltzer,M. Brian Fennerty,Irving Waxman,Krish Ragunath,Peter J. Kahrilas,Stephen Attwood,Michael Vieth,Kausilia K. Krishnadath,Gaius Longcroft-Wheaton,Rajvinder Singh,David Armstrong,Kenneth K. Wang,Pradeep Bhandari,David N. Poller,Lisa Yerian,Michio Hongo,Elaine W. Kay,Scott Sanders +28 more
Journal ArticleDOI
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme
Stephan Miehlke,Christoph Schlag,Alfredo J. Lucendo,Luc Biedermann,Cecilio Santander Vaquero,Christoph Schmoecker,Jamal O. Hayat,Petr Hruz,Constanza Ciriza de los Ríos,Albert J. Bredenoord,Michael Vieth,Alain M. Schoepfer,Stephen Attwood,Ralph Mueller,Sarah Burrack,Roland Greinwald,Alex Straumann +16 more
TL;DR: In this large prospective trial, a 6‐week open‐label treatment with BOT 1 mg BID was highly effective and safe in achieving clinico‐histological remission of active EoE and confirmed the results of the placebo‐controlled EOS‐1 trial.
Journal ArticleDOI
The development of an online standalone cognitive hazard training for laparoscopic cholecystectomy: a feasibility study.
TL;DR: The feasibility study supported the aim to enhance hazard awareness and create an attitude shift towards adherence to safety steps during the procedure, and supported this online resource value in enhancing knowledge and awareness.
Journal ArticleDOI
PTU-164 The clinical utility of the endoscopic functional luminal imaging probe in eosinophilic oesophagitis: a case series
TL;DR: The EndoFLIP may become a useful tool in the clinical assessment of EoE and may help to define the need for oesophageal dilatation and predict the outcome of such intervention.
Journal ArticleDOI
W1111 Safety Profile in GERD Patients 5 Yrs After Laparoscopic Antireflux Surgery or Long-Term Treatment With Esomeprazole 20-40mg Daily in the Lotus Study
Christian Ell,Lars Lundell,Christoph M. Seiler,Jean-Paul Galmiche,Roberto Fiocca,Jan Gunnar Hatlebakk,Birgitta Hasselgren,Göran Långström,Tore Lind,Stephen Attwood +9 more
TL;DR: No major concerns have arisen in safety data up to five years after LARS or daily esomeprazole treatment, and laboratory tests, including routine blood and liver variables, electrolytes, and also vitamin B12, folate, and homocysteine showed no clinically relevant change over time.